Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
68,794
Employees68,794
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
68,794
Employees68,794

NVO Key Statistics

Market cap
209.33B
Market cap209.33B
Price-Earnings ratio
11.88
Price-Earnings ratio11.88
Dividend yield
2.53%
Dividend yield2.53%
Average volume
12.26M
Average volume12.26M
High today
$48.24
High today$48.24
Low today
$46.87
Low today$46.87
Open price
$47.80
Open price$47.80
Volume
5.46M
Volume5.46M
52 Week high
$64.16
52 Week high$64.16
52 Week low
$35.12
52 Week low$35.12

NVO News

Nasdaq 6h
NVO vs. GPCR: Which Obesity Stock Is the Better Buy Right Now?

Novo Nordisk NVO and Structure Therapeutics GPCR have emerged as noteworthy companies in the obesity space. A market leader in the GLP-1 space, Novo Nordisk ma...

NVO vs. GPCR: Which Obesity Stock Is the Better Buy Right Now?
Simply Wall St 18h
Novo Nordisk Stock May Trade Below Fair Value Despite Obesity Market Lawsuit

Novo Nordisk stock combines a weak three year share price record with valuation checks that still lean supportive, which raises questions about how much pessimi...

Novo Nordisk Stock May Trade Below Fair Value Despite Obesity Market Lawsuit
TipRanks 24h
PepsiCo ending coverage for prescription weight-loss drugs, Bloomberg reports

Some PepsiCo (PEP) employees were notified this week that weight-loss drugs such as Novo Nordisk’s (NVO) Wegovy and Eli Lilly’s (LLY) Zepbound will no longer be...

Analyst ratings

50%

of 6 ratings
Buy
33.3%
Hold
50%
Sell
16.7%

More NVO News

TipRanks 1d
Novo Nordisk’s AMAZE 7 Trial Pits Next-Gen Obesity Drug Against Semaglutide

Novo Nordisk (NVO) announced an update on their ongoing clinical study. The AMAZE 7 study, officially titled “Efficacy and Safety of Zenagamtide s.c. Once-week...

TipRanks 1d
Novo Nordisk price target raised to DKK 275 from DKK 250 at JPMorgan

JPMorgan raised the firm’s price target on Novo Nordisk (NVO) to DKK 275 from DKK 250 and keeps a Neutral rating on the shares. Published first on TheFly – the...

24/7 Wall St. 1d
Eli Lilly vs Novo Nordisk: One Winner in The Weight-Loss Drug Gold Rush

Eli Lilly vs Novo Nordisk: One Winner in The Weight-Loss Drug Gold Rush By Vandita Jadeja Published Aug 25, 10:30AM EDT Quick Read LLY posted 48% revenue grow...

Eli Lilly vs Novo Nordisk: One Winner in The Weight-Loss Drug Gold Rush
TipRanks 2d
Novo Nordisk’s AMAZE 9 Oral Obesity Trial: A New Pill in the Weight-Loss Race

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident i...

TipRanks 2d
Novo Nordisk Details Progress in DKK 15 Billion Share Buyback Programme

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

TipRanks 2d
Lexicon earns third $10M milestone payment from Novo Nordisk for LX9851

Lexicon (LXRX) announced that it has earned a third $10M milestone payment in 2026 from Novo Nordisk (NVO) following the achievement of a patient dosing milesto...

Nasdaq 3d
Eli Lilly and Novo Nordisk Can't Treat This Form of Obesity. Billionaire Stanley Druckenmiller Is Betting Rhythm Pharmaceuticals Can

Key Points Rhythm Pharmaceuticals develops medicines for rare forms of obesity. The company has little competition in its target market. The stock looks prom...

Eli Lilly and Novo Nordisk Can't Treat This Form of Obesity. Billionaire Stanley Druckenmiller Is Betting Rhythm Pharmaceuticals Can

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.